Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.24 -0.59 (-7.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Change in Acquisitions & Divestments (2026)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Change in Acquisitions & Divestments of -$79.72 million in the quarter ended Mar 31, 2026.

Analysis

Eupraxia Pharmaceuticals (EPRX) Change in Acquisitions & Divestments (2026) Analysis & Trends

For the year ended Dec 31, 2025, Eupraxia Pharmaceuticals reported Change in Acquisitions & Divestments of $80.56 million, up 143.4% from the prior year.

  • Annual Change in Acquisitions & Divestments has increased for three straight years, with a three-year compound annual growth rate of 82.1% (years ended Dec 2022 to Dec 2025).
  • Across earlier years, Change in Acquisitions & Divestments came in at $33.1 million in the year ended Dec 31, 2024 (+71.1%), $19.34 million in the year ended Dec 31, 2023 (+45.0%) and $13.34 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Eupraxia Pharmaceuticals 289.28 Mn 287.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -79.72 Mn
API Access

Eupraxia Pharmaceuticals Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=EPRX&period=max&api_key=YOUR_API_KEY